111 related articles for article (PubMed ID: 2856456)
21. [Motor and endocrine function disturbances of the gastrointestinal tract in patients with chronic renal failure (CRF)].
Dobrek L; Błaut U; Zurowskii D; Mazur M; Stojakowska M; Smoleński O; Thor PJ
Folia Med Cracov; 2005; 46(1-2):65-73. PubMed ID: 17037288
[TBL] [Abstract][Full Text] [Related]
22. The endocrine system in patients with acute renal failure.
Kokot F
Proc Eur Dial Transplant Assoc; 1981; 18():617-29. PubMed ID: 7329989
[No Abstract] [Full Text] [Related]
23. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
24. Endocrine disorders in chronic hemodialysis patients (with the exclusion of hyperparathyroidism).
Drüeke T
Adv Nephrol Necker Hosp; 1981; 10():351-82. PubMed ID: 6267908
[No Abstract] [Full Text] [Related]
25. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
26. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
Ivić M; Strahinjić S; Stefanović V
Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
[No Abstract] [Full Text] [Related]
28. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
Weinberg MS; Weinberg AJ; Zappe DH
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
[No Abstract] [Full Text] [Related]
29. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
30. Endocrine disorders. Introduction.
Horwitz DL
Compr Ther; 1980 Aug; 6(8):7-11. PubMed ID: 6250764
[No Abstract] [Full Text] [Related]
31. Importance of blood pressure control in chronic kidney disease.
Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of hemodynamic regulation in patients with chronic renal insufficiency during hemodialysis].
Aliev MA; Verbolovich VP; Teplova LL; Lukina OM; Markova GE
Urol Nefrol (Mosk); 1986; (3):46-50. PubMed ID: 3739098
[No Abstract] [Full Text] [Related]
33. [The endocrine system and aging].
Gerlach J
Pol Tyg Lek; 1982 Sep; 37(34-35):1025-7. PubMed ID: 6761662
[No Abstract] [Full Text] [Related]
34. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
35. Obesity, proteinuria and progression of renal failure.
Praga M; Morales E
Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):481-6. PubMed ID: 16914959
[TBL] [Abstract][Full Text] [Related]
36. Is hypertension in chronic renal failure neurogenic in nature?
Campese VM
Nephrol Dial Transplant; 1994; 9(7):741-2. PubMed ID: 7970112
[No Abstract] [Full Text] [Related]
37. Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.
Ledingham JG
Kidney Int Suppl; 1987 May; 20():S112-6. PubMed ID: 3037159
[No Abstract] [Full Text] [Related]
38. Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
Kutyrina IM; Nikishova TA; Tareyeva IE
Nephrol Dial Transplant; 1987; 2(4):219-23. PubMed ID: 3118260
[TBL] [Abstract][Full Text] [Related]
39. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
Steele JL; Henik RA; Stepien RL
Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
[TBL] [Abstract][Full Text] [Related]
40. The renin-angiotensin-aldosterone system in primary and secondary hypertension.
del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S
Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
